See more : Bumrungrad Hospital Public Company Limited (BH.BK) Income Statement Analysis – Financial Results
Complete financial analysis of Noble Helium Limited (NHE.AX) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Noble Helium Limited, a leading company in the Chemicals – Specialty industry within the Basic Materials sector.
- Beijing Tong Ren Tang Chinese Medicine Company Limited (BJTRF) Income Statement Analysis – Financial Results
- Mitesco, Inc. (MITI) Income Statement Analysis – Financial Results
- Santa Cruz County Bank (SCZC) Income Statement Analysis – Financial Results
- Omai Gold Mines Corp. (OMGGF) Income Statement Analysis – Financial Results
- Lam Soon (Thailand) Public Company Limited (LST.BK) Income Statement Analysis – Financial Results
Noble Helium Limited (NHE.AX)
About Noble Helium Limited
Noble Helium Limited engages in the exploration of helium projects in Tanzania. The company holds 100% interests in the North Rukwa Basin project with 12 granted prospecting licenses covering a combined area of approximately 1,467 square kilometers located in south-west Tanzania; and the North Nyasa Basin project with 2 granted prospecting licenses that cover a combined area of approximately 466 square kilometers located in south-west Tanzania. It also holds 100% interests in the Eyasi and Manyara Basin project with 9 applications for prospecting licenses covering a combined area of approximately 1,992 square kilometers located in central northern Tanzania. The company was incorporated in 2015 and is based in Perth, Australia.
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 23.89K | 16.26K |
| Cost of Revenue | 233.18K | 72.91K | 77.64K | 0.00 | 0.00 | 0.00 |
| Gross Profit | -233.18K | -72.91K | -77.64K | 0.00 | 23.89K | 16.26K |
| Gross Profit Ratio | 0.00% | 0.00% | 0.00% | 0.00% | 100.00% | 100.00% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 751.72K | 1.31M | 1.61M | 121.94K | 271.89K | 183.76K |
| Selling & Marketing | 2.45M | 1.10M | 0.00 | 3.04K | 58.18K | 34.79K |
| SG&A | 3.20M | 2.42M | 1.61M | 124.99K | 330.07K | 218.55K |
| Other Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Expenses | 3.20M | 2.42M | 2.73M | 124.99K | 330.07K | 218.55K |
| Cost & Expenses | 3.20M | 2.49M | 2.73M | 124.99K | 330.07K | 218.55K |
| Interest Income | 0.00 | 50.59K | 941.00 | 40.43K | 0.00 | 0.00 |
| Interest Expense | 0.00 | 0.00 | 17.30K | 0.00 | 0.00 | 0.00 |
| Depreciation & Amortization | 233.18K | 72.91K | 77.64K | 124.99K | 306.18K | 202.29K |
| EBITDA | -3.22M | -2.37M | -2.65M | -40.43K | -3.00 | 3.00 |
| EBITDA Ratio | 0.00% | 0.00% | 0.00% | 0.00% | -1,381.45% | -1,344.34% |
| Operating Income | -3.20M | -2.49M | -2.73M | -124.99K | -330.07K | -218.55K |
| Operating Income Ratio | 0.00% | 0.00% | 0.00% | 0.00% | -1,381.45% | -1,344.34% |
| Total Other Income/Expenses | -1.86M | 50.59K | -16.36K | -40.43K | 0.00 | 16.26K |
| Income Before Tax | -5.06M | -2.44M | -2.75M | -165.42K | -306.18K | -202.29K |
| Income Before Tax Ratio | 0.00% | 0.00% | 0.00% | 0.00% | -1,281.44% | -1,244.35% |
| Income Tax Expense | 0.00 | -3.00 | -150.85K | -124.99K | -306.18K | -202.29K |
| Net Income | -5.06M | -2.44M | -2.75M | -165.42K | -306.18K | -202.29K |
| Net Income Ratio | 0.00% | 0.00% | 0.00% | 0.00% | -1,281.44% | -1,244.35% |
| EPS | -0.01 | -0.01 | -0.02 | 0.00 | 0.00 | 0.00 |
| EPS Diluted | -0.01 | -0.01 | -0.02 | 0.00 | 0.00 | 0.00 |
| Weighted Avg Shares Out | 399.28M | 211.36M | 138.28M | 183.16M | 183.16M | 183.16M |
| Weighted Avg Shares Out (Dil) | 399.28M | 211.36M | 138.28M | 183.16M | 183.16M | 183.16M |
Source: https://incomestatements.info
Category: Stock Reports